Theodore W. Laetsch

Also affiliated with University of Pennsylvania, Philadelphia University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.705Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Papers

Driven by 38 papers — median percentile 49. Top paper: “Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL”.

Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL

Journal of Clinical Oncology(2021)10.1200/jco.21.01405

N/A

0.801DataRank · unranked

208 citations

Agne Taraseviciute, Seth M. Steinberg, Adam J. Lamble, Jennifer Sheppard, Bonnie Yates +23 more

Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0095

N/A

0.785DataRank · unranked

186 citations

Xia Han, Shannon L. Maude, Theodore W. Laetsch, Muna Qayed, Susana Rives +17 more

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells

Blood Advances(2022)10.1182/bloodadvances.2022007423

N/A

0.749DataRank · unranked

146 citations

Regina M. Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M. Steinberg +24 more

Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy

Blood Advances(2022)10.1182/bloodadvances.2022008093

N/A

0.533DataRank · unranked

34 citations

Regina M. Myers, Bonnie Yates, Colleen Annesley, Samuel John, Agne Taraseviciute +17 more

HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

Blood Advances(2023)10.1182/bloodadvances.2022008893

N/A

0.515DataRank · unranked

30 citations

Stephanie J. Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, John J. Chen +28 more

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Update for NCI-COG Pediatric MATCH: Active trial cohorts for children, adolescents and young adults with refractory cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps10071

Top 59%

0.257DataRank

Top 59%3 citations

Katherine A. Janeway, Theodore W. Laetsch, Meredith S. Irwin, Elizabeth Alva, Christine A. Pratilas +14 more

Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.23.453235

N/A

0DataRank · unranked

10 citations

Julio C. Ricarte‐Filho, Amber Isaza, Zachary Jones, N. Jain, Sogol Mostoufi‐Moab +10 more

Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia

Journal of Clinical Oncology(2022)10.1200/jco.22.01076

N/A

0DataRank · unranked

73 citations

Anne Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Amy K. Keating +26 more

A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1169

N/A

0DataRank · unranked

32 citations

Dan G. Duda, Genevieve Bergendahl, David H. Ebb, Matija Snuderl, Theodore W. Laetsch +11 more

The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer

Cancer Genetics(2022)10.1016/j.cancergen.2022.01.002

N/A

0DataRank · unranked

24 citations

Stephen Halada, A. O’Neill, Victoria Casado‐Medrano, Theodore W. Laetsch, Aime T. Franco +2 more

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)

Haematologica(2022)10.3324/haematol.2021.279520

N/A

0DataRank · unranked

20 citations

Lewis B. Silverman, James A. Whitlock, Richard Sposto, Joseph P. Loftus, Eric S. Schafer +13 more

Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions

Cancer Genetics(2022)10.1016/j.cancergen.2022.03.001

N/A

0DataRank · unranked

10 citations

Alanna J. Church, Shruti Rao, Arpad Danos, Larissa V. Furtado, Theodore W. Laetsch +11 more

Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective

EJC Paediatric Oncology(2023)10.1016/j.ejcped.2023.100024

N/A

0DataRank · unranked

11 citations

Murali Chintagumpala, Jin Piao, Kenneth S. Chen, Rachana Shah, Robyn D. Gartrell +15 more

Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102268

N/A

0DataRank · unranked

11 citations

Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen, Holly Pacenta +23 more

Opportunities and Challenges in Drug Development for Pediatric Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0779

N/A

0DataRank · unranked

73 citations

Steven G. DuBois, Julia Glade Bender, Margaret E. Macy, Lucas Moreno, Theodore W. Laetsch

Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.10.004

N/A

0DataRank · unranked

8 citations

Amy Moskop, Lena E. Winestone, Christina Baggott, Julie‐An Talano, Deborah Schiff +6 more

INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.07.016

N/A

0DataRank · unranked

10 citations

Elad Jacoby, Michael A. Pulsipher, Marcelo C. Pasquini, Stephan A. Grupp, Nirali N. Shah +4 more

Children's Oncology Group's 2023 blueprint for research: Rare tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30574

N/A

0DataRank · unranked

4 citations

Murali Chintagumpala, Jin Piao, Kenneth S. Chen, Robyn D. Gartrell, Emily Christison‐Lagay +4 more

SARC037: Results of phase I study of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11519

N/A

0DataRank · unranked

14 citations

Karla V. Ballman, Rachel S. Heise, John Glod, Mary Frances Wedekind, Leo Mascarenhas +15 more

Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10008

N/A

0DataRank · unranked

5 citations

Kathleen Ludwig, David Hall, Donald A. Barkauskas, Stephan D. Voss, Steven G. DuBois +12 more

Data from A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma

(2023)10.1158/1078-0432.c.6532608

N/A

0DataRank · unranked

0 citations

Dan G. Duda, Genevieve Bergendahl, David H. Ebb, Matija Snuderl, Theodore W. Laetsch +11 more

Data from A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma

(2023)10.1158/1078-0432.c.6532608.v1

N/A

0DataRank · unranked

0 citations

Dan G. Duda, Genevieve Bergendahl, David H. Ebb, Matija Snuderl, Theodore W. Laetsch +11 more

Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group

Journal of Clinical Oncology(2024)10.1200/jco.24.01154

N/A

0DataRank · unranked

21 citations

Raymond L. Barnhill, David E. Elder, Susan M. Swetter, Víctor G. Prieto, Jennifer S. Ko +28 more

Racial and Ethnic Survival Disparities in Pediatric Oncology Over Time: An Analysis of the SEER Registry

Journal of Pediatric Surgery(2024)10.1016/j.jpedsurg.2024.161953

N/A

0DataRank · unranked

3 citations

Shalini Sahoo, Theodore W. Laetsch, Gregory M. Tiao, Minerva Mayorga‐Carlin, Yelena Yesha +4 more

SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11508

N/A

0DataRank · unranked

13 citations

Karla V. Ballman, Rachel S. Heise, Leo Mascarenhas, John Glod, Mary Frances Frances Wedekind +14 more

Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement

The Lancet Diabetes & Endocrinology(2025)10.1016/s2213-8587(25)00064-6

N/A

0DataRank · unranked

28 citations

Laura Boucai, Naifa L. Busaidy, Cosimo Durante, James A. Fagin, Sasan Fazeli +12 more

Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma

Endocrine Reviews(2025)10.1210/endrev/bnaf003

N/A

0DataRank · unranked

12 citations

T. Lai, Theodore W. Laetsch, Tricia Bhatti, Zubair Baloch, Lea F. Surrey +7 more

Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel

Blood Advances(2025)10.1182/bloodadvances.2025016824

N/A

0DataRank · unranked

2 citations

Subodh Selukar, Aimee C. Talleur, Samira Deshpande, Gabriela Llaurador Caraballo, Vanessa A. Fabrizio +34 more

Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children’s Oncology Group

European Journal of Cancer(2025)10.1016/j.ejca.2025.115600

N/A

0DataRank · unranked

1 citations

David P. Douglass, Sapna Oberoi, Natalie B. Collins, Ajay Gupta, Jonathan Metts +17 more

Rare but not forgotten: Therapeutic advancements for rare childhood cancers

Molecular Therapy Oncology(2025)10.1016/j.omton.2025.201084

N/A

0DataRank · unranked

0 citations

Urania Dagalakis, Robyn D. Gartrell, Kris Ann P. Schultz, Theodore W. Laetsch, Jacquelyn Crane

Safety of current treatment options for NTRK fusion-positive cancers

Expert Opinion on Drug Safety(2023)10.1080/14740338.2023.2274426

N/A

0DataRank · unranked

9 citations

Theodore W. Laetsch, Adeline Yang

The effect of injected dose on localized tumor accumulation and cardiac uptake of doxorubicin in a Vx2 rabbit tumor model using MR-HIFU mild hyperthermia and thermosensitive liposomes

International Journal of Hyperthermia(2020)10.1080/02656736.2020.1812737

N/A

0DataRank · unranked

10 citations

Chenchen Bing, Robert Staruch, Sumbul Shaikh, Michelle Wodzak Staruch, Debra Szczepanski +4 more

542P Growth modulation index (GMI) of larotrectinib versus prior systemic treatments for TRK fusion cancer patients

Annals of Oncology(2020)10.1016/j.annonc.2020.08.656

N/A

0DataRank · unranked

3 citations

David S. Hong, Andrew Briggs, Jesús García‐Foncillas, Ulrik Lassen, Gilles Vassal +9 more

A phase II study of larotrectinib for children with newly diagnosed solid tumors and relapsed acute leukemias harboring TRK fusions: Children’s Oncology Group study ADVL1823.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps10560

N/A

0DataRank · unranked

2 citations

Kathleen Ludwig, Donald A. Barkauskas, Steven G. DuBois, Joan Ronan, Erin R. Rudzinski +10 more

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Blood Advances(2021)10.1182/bloodadvances.2021006418

N/A

0DataRank · unranked

113 citations

Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler +27 more

Beyond the storm — subacute toxicities and late effects in children receiving CAR T cells

Nature Reviews Clinical Oncology(2021)10.1038/s41571-020-00456-y

N/A

0DataRank · unranked

68 citations

Juliane Gust, Agne Taraseviciute, Pamela L. Wolters, Allison Barz Leahy, Carlos Sandi +16 more

Oncogene-specific inhibition in the treatment of advanced pediatric thyroid cancer

Journal of Clinical Investigation(2021)10.1172/jci152696

N/A

0DataRank · unranked

15 citations

Julio C. Ricarte‐Filho, Theodore W. Laetsch, Andrew J. Bauer, Aime T. Franco

Theodore W. Laetsch

Indexed papers

Top data-sharing exemplar

Papers